Contents
<aside> 💬 Our overarching mission is to accelerate the mass-market adoption of consumer biotech products so every human can live at least 100 healthy years.
Our immediate focus is excess bodyweight. We are increasing the accessibility of GLP-1 medications to accelerate their take-up to help solve obesity worldwide.
To do that, we’re building the AI-powered Clinical Operating System for Direct-to-Patient Healthcare: ClinicOS. ClinicOS makes it effortless for consumer brands to launch, run, and grow their own global direct-to-patient clinic. We work with external Brand Partners, as well as using this infrastructure to scale our own internal consumer healthcare brands.
If we succeed, our infrastructure will have served 100 million patients worldwide by 2035.
We’ll then use that direct-to-patient infrastructure to serve next-gen biotech products at-scale to increase the proportion of humans living at least 100 healthy years.
In so doing, we’ll become the world’s first trillion dollar healthcare company.
</aside>
<aside> 📈 We’ve grown >2000x since Aug 2021, >200x since Aug 2022, >20x since Aug 2023. We’re >$50M ARR. We’ve been cashflow positive since June 2023. We’re >10,000 customers with high NPS.
We’re a young startup and we’re just getting started. This is still Day 1 and all our work is ahead of us.
</aside>